| Date Filed | Type | Description |
| 06/09/2023 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
| 08/23/2022 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Granted 25,000 options
@ $12.38, valued at
$309.5k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
3
| Gerberding Julie L. (Director) has filed a Form 3 on HilleVax, Inc. |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Gerberding Julie L. (EVP, Chief Patient Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 96,270 shares
@ $87.9057, valued at
$8.5M
Exercised 35,287 options to buy
@ $0
Exercised 30,175 options to buy
@ $0
Exercised 19,394 options to buy
@ $0
Exercised 11,414 options to buy
@ $0 |
|
| 08/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2020 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on CERNER Corp|
Txns:
| Granted 3,716 shares
@ $0 |
|
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 49,536 shares
@ $0
Exercised 33,012 shares
@ $0
Sold 102,073 shares
@ $89.3367, valued at
$9.1M
Exercised 49,536 options to buy
@ $59.86, valued at
$3M
Exercised 33,012 options to buy
@ $58.22, valued at
$1.9M
|
|
| 08/23/2019 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on CERNER Corp|
Txns:
| Sold 7,928 shares
@ $71.82, valued at
$569.4k
|
|
| 06/03/2019 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on CERNER CORP /MO/|
Txns:
| Granted 3,556 shares
@ $0 |
|
| 05/07/2019 |
4
| Gerberding Julie L. (EVP Strat Comm, GI Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 28,227 options to buy
@ $80, valued at
$2.3M
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2018 |
4
| Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 36,218 shares
@ $75.138, valued at
$2.7M
Exercised 36,218 options to buy
@ $54.68, valued at
$2M
|
|
| 05/22/2018 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on CERNER CORP /MO/|
Txns:
| Granted 4,100 shares
@ $0 |
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2018 |
4
| Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 29,277 options to buy
@ $57.75, valued at
$1.7M
|
|
| 03/01/2018 |
4
| Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 9,062 shares
@ $54.72, valued at
$495.9k
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/08/2016 |
4
| Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 85,523 shares
@ $60.0228, valued at
$5.1M
Exercised 36,563 options to buy
@ $39.29, valued at
$1.4M
Exercised 10,313 options to buy
@ $36.56, valued at
$377k
Exercised 38,647 options to buy
@ $44.98, valued at
$1.7M
|
|
| 05/12/2016 |
4
| Gerberding Julie L. (EVP Strat Comm, Gl Pub Policy) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 54,329 options to buy
@ $54.68, valued at
$3M
|
|